Dialog Box

Skin Health Institute

Transplant Clinic

Transplant patients have unique dermatological needs, including:

  • infective skin problems
  • numerous precancerous lesions (actinic keratoses, Bowen's disease)
  • skin cancers. 

Immunosuppressant drugs used by transplant patients increase the risk of skin cancers. Squamous cell carcinomas (SCC) are the most common post-transplant malignancy.

Their problems are often multiple, complex and time consuming.

The Skin Health Institute's Transplant Clinic is set up to manage the skin of patients who have had organ transplants.


Associate Professor Alvin Chong                                                                          

Dr Aaron Robinson

Dr Sarah Brennand

Dr Michelle Goh

Dr Rebecca Dunn

Dr Jane Li

Further Information

Download the brochure

skin cancer database

Patients are invited to take part in this research project, Skin Health Institute Skin Cancer Database. The research project is aiming to collect information about people who are immunosuppressed, have received an organ transplant, and people who are at high risk of developing skin cancer for other reasons.

More information can be found in the  Participant Information Sheet/Consent Form. If a patient would like to participate, we encourage them to complete the form prior to their appointment.

Participation in this research is voluntary, and patients will receive the best possible care whether or not they take part.

Patient Information Sheet